Page last updated: 2024-10-24

celecoxib and Abdominal Neoplasms

celecoxib has been researched along with Abdominal Neoplasms in 1 studies

Abdominal Neoplasms: New abnormal growth of tissue in the ABDOMEN.

Research Excerpts

ExcerptRelevanceReference
"To validate the efficacy of an innovative multimodality therapy with transcatheter arterial embolization (TAE) plus octreotide and celecoxib in reducing neoangiogenesis and prolonging the survival of rabbits with hepatocellular carcinoma."3.79Transcatheter arterial embolization followed by octreotide and celecoxib synergistically prolongs survival of rabbits with hepatic VX2 allografts. ( Fu, P; Gao, JH; Huang, ZY; Li, X; Tang, CW; Tong, H; Wen, FQ; Wen, SL; Zhang, CL, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tong, H1
Li, X1
Zhang, CL1
Gao, JH1
Wen, SL1
Huang, ZY1
Wen, FQ1
Fu, P1
Tang, CW1

Other Studies

1 other study available for celecoxib and Abdominal Neoplasms

ArticleYear
Transcatheter arterial embolization followed by octreotide and celecoxib synergistically prolongs survival of rabbits with hepatic VX2 allografts.
    Journal of digestive diseases, 2013, Volume: 14, Issue:1

    Topics: Abdominal Neoplasms; Analysis of Variance; Animals; Antineoplastic Combined Chemotherapy Protocols;

2013